Literature DB >> 8688762

Rapidly reversible increase in insulin requirement with interferon.

S Campbell1, E H Mclaren, B J Danesh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8688762      PMCID： PMC2351482          DOI： 10.1136/bmj.313.7049.92a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.

Authors:  P Fabris; C Betterle; A Floreani; N A Greggio; F de Lazzari; R Naccarato; M Chiaramonte
Journal:  Lancet       Date:  1992-08-29       Impact factor: 79.321

2.  Effect of interferon on glucose tolerance and insulin sensitivity.

Authors:  V A Koivisto; R Pelkonen; K Cantell
Journal:  Diabetes       Date:  1989-05       Impact factor: 9.461
  2 in total
  2 in total

1.  Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.

Authors:  B Wesche; E Jaeckel; C Trautwein; H Wedemeyer; A Falorni; H Frank; A von zur Mühlen; M P Manns; G Brabant
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

2.  Glucose intolerance in Chinese patients with chronic hepatitis C.

Authors:  Liang-Kung Chen; Shinn-Jang Hwang; Shih-Tzer Tsai; Jiing-Chyuan Luo; Shou-Dong Lee; Full-Young Chang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.